Ursodiol for Primary Sclerosing Cholangitis
- 6 March 1997
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 336 (10) , 691-695
- https://doi.org/10.1056/nejm199703063361003
Abstract
There is no satisfactory medical therapy for patients with primary sclerosing cholangitis. Ursodiol (ursodeoxycholic acid) benefits patients with primary biliary cirrhosis, another cholestatic liver disease.Keywords
This publication has 18 references indexed in Scilit:
- Colchicine treatment of primary sclerosing cholangitisGastroenterology, 1995
- Primary Sclerosing CholangitisNew England Journal of Medicine, 1995
- Ursodiol for the Long-Term Treatment of Primary Biliary CirrhosisNew England Journal of Medicine, 1994
- Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study periodJournal of Hepatology, 1994
- Immunohistochemical Characterization of Hepatic Lymphocytes in Primary Biliary Cirrhosis in Comparison With Primary Sclerosing Cholangitis and Autoimmune Chronic Active HepatitisMayo Clinic Proceedings, 1993
- Ursodeoxycholic Acid for Treatment of Primary Sclerosing Cholangitis: A Placebo–Controlled TrialHepatology, 1992
- Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: A 30-month pilot studyHepatology, 1991
- Ursodeoxycholic acid for primary sclerosing cholangitisJournal of Hepatology, 1990
- Therapeutic investigations in primary sclerosing cholangitisDigestive Diseases and Sciences, 1986
- Biliary lavage with corticosteroids in primary sclerosing cholangitisJournal of Hepatology, 1986